Green Square Capital Advisors LLC Amgen Inc Transaction History

Green Square Capital Advisors LLC

$723 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $19,443 - $23,628	74 Added 5.77%	1,357 $423,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $80,661 - $97,368	300 Added 30.52%	1,283 $364,000
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $5,114 - $5,769	-20 Reduced 1.99%	983 $283,000
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $22,739 - $28,231	-104 Reduced 9.39%	1,003 $269,000
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $53,567 - $63,342	250 Added 29.17%	1,107 $245,000
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $196,278 - $249,395	857 New	857 $225,000
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $194,014 - $227,311	-914 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $10,043 - $11,143	43 Added 4.94%	914 $223,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $984,745 - $1.17 Million	-4,551 Reduced 83.94%	871 $200,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $221,040 - $245,814	-942 Reduced 14.8%	5,422 $1.38 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $155,676 - $191,036	-787 Reduced 11.01%	6,364 $1.5 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $140,324 - $186,109	-770 Reduced 9.72%	7,151 $1.45 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $11,163 - $14,348	59 Added 0.75%	7,921 $1.91 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $22,460 - $26,911	-129 Reduced 1.61%	7,862 $1.52 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $47,842 - $56,082	287 Added 3.73%	7,991 $1.47 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $5.89 Million - $6.63 Million	-32,541 Reduced 80.86%	7,704 $1.46 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $556,251 - $649,323	-3,118 Reduced 7.19%	40,245 $7.84 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $769,138 - $867,102	4,151 Added 10.59%	43,363 $8.99 Million
Q2 2018 Aug 20, 2018	SELL	$166.05 - $186.51 $827,759 - $929,752	-4,985 Reduced 11.28%	39,212 $7.24 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $552,341 - $645,480	-3,260 Reduced 6.87%	44,197 $7.54 Million
Q4 2017 Feb 22, 2018	BUY	$168.79 - $188.59 $1.22 Million - $1.36 Million	7,231 Added 17.98%	47,457 $8.25 Million
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $84,648 - $96,646	-506 Reduced 1.24%	40,226 $7.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,732	40,732 $7.02 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

Vanguard Group Inc Valley Forge, PA

52.7M
Shares

$15.4 Billion
0.25% of portfolio
Black Rock Inc. New York, NY

46M
Shares

$13.4 Billion
0.33% of portfolio
State Street Corp Boston, MA

29.4M
Shares

$8.57 Billion
0.31% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$4.24 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

13.2M
Shares

$3.84 Billion
0.65% of portfolio

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Square Capital Advisors LLC with notifications on news.

Account